Skip to main navigation Skip to search Skip to main content

Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients

  • C. M. Nijenhuis
  • , A. D.R. Huitema
  • , C. Blank
  • , J. B.A.G. Haanen
  • , J. V. van Thienen
  • , H. Rosing
  • , J. H.M. Schellens
  • , J. H. Beijnen

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)
Original languageEnglish
Pages (from-to)125-128
Number of pages4
JournalJournal of Clinical Pharmacology
Volume57
Issue number1
DOIs
Publication statusPublished - Jan 2017
Externally publishedYes

Keywords

  • LC-MS/MS
  • exposure-response
  • pharmacokinetics
  • routine clinical care
  • therapeutic drug monitoring
  • vemurafenib

Cite this